The major aim of this study was to estimate and compare the patient-borne costs of lifelong subcutaneous gamma globulin therapy at the hospital and at home.
Thirty patients were included and the data were collected with a questionnaire.
The introduction of self-therapy at home reduced the total yearly costs by approximately 50% and the out-of-pocket expenses for the patients by 85%.
Mots-clés Pascal : Globuline gamma, Chimiothérapie, Traitement, Immunomodulateur, Voie souscutanée, Autoadministration, A domicile, Milieu hospitalier, Etude comparative, Analyse coût, Economie santé
Mots-clés Pascal anglais : Globulin gamma, Chemotherapy, Treatment, Immunomodulator, Subcutaneous administration, Self administration, At home, Hospital environment, Comparative study, Cost analysis, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0429468
Code Inist : 002B02Q. Création : 01/03/1996.